Pharma 4.0: Eliminating Human Errors In Pharmaceutical Industry

Human errors in the pharmaceutical industry are a cost burden for all participants in the supply chain. 30-40% of all deviations are being caused by some form of human failure in operative handling. Even in cases where the error is considered minor, there has to be extensive investigation and testing to confirm the root cause.
And with medical drug products becoming ever more complex, the root cause analysis procedures as well as the corrective and preventive actions required are becoming increasingly elaborate too. But how can Pharma 4.0 contribute to minimize human error in pharmaceutical manufacturing?
We review the types of and reasons for human errors in pharmaceutical industry and how the implementation of Pharma 4.0 standards and SOPs aims to reduce the different types of human error through the automation of processes that have traditionally involved human performance.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.